Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
December 18, 2020 - The FDA approved Merz Pharmaceuticals’ Xeomin (incobotulinumtoxinA), for the treatment of chronic sialorrhea in patients 2 years of age and older.
